🛡 Psychedelic Microdosing Evidence Gap Simulator

Self-Reported Microdosing Benefits

Anecdotes describe better mood and focus but carry no control comparison.

• ~1000s: Survey respondents (placeholder cohort size)
• ~70%: Reported benefit rate (placeholder self-report figure)
• None: Comparison group (placeholder study design note)
• High: Expectancy bias risk (placeholder risk rating)

Why anecdotes drive early interest

Placeholder: personal stories spread quickly online and shape belief.

Uncontrolled Observational Data

Open-label studies track self-selected users without blinding.

• Open-label: Study design (placeholder design type)
• High: Selection bias (placeholder bias rating)
• Variable: Sample retention (placeholder retention note)
• Absent: Placebo arm (placeholder design gap)

Limits of observational tracking

Placeholder: motivated volunteers likely differ from typical users.

Randomized Placebo-Controlled Trials

Blinded capsule trials compare microdose against inert placebo.

• Yes: Randomization (placeholder trial feature)
• Double-blind: Blinding method (placeholder method note)
• Weeks: Typical duration (placeholder trial length)
• Minimal: Effect vs placebo (placeholder trial result)

Why controlled design matters

Placeholder: only comparison groups reveal true drug effect size.

The Blinding Failure Problem

Subtle perceptual cues let participants guess their assigned group.

• ~80%: Correct guess rate (placeholder unblinding figure)
• Strong: Expectancy effect (placeholder effect rating)
• Rare: Active placebo use (placeholder methodology gap)
• Inflates benefit: Bias direction (placeholder bias note)

Why blinding breaks down

Placeholder: mild sensory effects reveal drug versus placebo status.

Current State of the Evidence Gap

Most rigorous trials find effects indistinguishable from placebo.

• Few: Trials showing benefit (placeholder trial summary)
• Low: Overall confidence (placeholder confidence rating)
• More RCTs: Research need (placeholder research gap)
• Mismatch: Public belief vs data (placeholder gap summary)

Where the science currently stands

Placeholder: strong belief persists despite weak controlled evidence.

Placeholder: the evidence gap remains wide and unresolved.